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Neurite outgrowthβ- and γ-secretase cleave the amyloid precursor protein (APP) to release the amyloidogenic β-amyloid
peptides (Aβ) and the APP intracellular domain (AICD). Aβ has been widely believed to initiate pathogen-
ic cascades culminating in Alzheimer's disease (AD). However, the physiological functions of the AICD re-
main elusive. In this study, we found the AICD to strongly inhibit Wnt-induced transcriptional reporter
activity, and to counteract Wnt-induced c-Myc expression. Loss of the AICD resulted in an increased re-
sponsiveness to Wnt/β-catenin-mediated transcription. Mechanically, the AICD was found to interact
with glycogen synthase kinase 3 beta (GSK3β) and promote its kinase activity. The subsequent AICD-
strengthened Axin–GSK3β complex potentiates β-catenin poly-ubiquitination. Functional studies in N2a
mouse neuroblastoma cells, rat pheochromocytoma PC12 cells and primary neurons showed that the
AICD facilitated neurite outgrowth. And AICD antagonised Wnt3a-suppressed growth arrest and neurite
outgrowth in N2a and PC12 cells. Taken together, our results identify the AICD as a novel inhibitory factor
of the canonical Wnt signalling pathway and suggest its regulatory role in neuronal cell proliferation and
differentiation.
Crown Copyright © 2012 Published by Elsevier B.V. All rights reserved.1. Introduction
The Wnt family is a group of secreted proteins that regulate
many biological processes, including embryonic development and
tumourigenesis, by affecting cell proliferation and differentiation
[1–4]. Cytosolic β-catenin is rapidly phosphorylated and degraded
through the proteasome system by the APC–Axin–GSK3β complex in
the absence of a Wnt ligand [5,6]. Wnt induces co-receptor signalling
via frizzled (Fz) and low-density lipoprotein receptor-related protein-5
or 6 (LRP-5/6), which recruits Dishevelled (Dvl) to the plasma mem-
brane along with the Axin–GSK3β complex. This results in the release
of β-catenin to induce transcription in the nucleus [2,7–11]. The kinase
activity of GSK3β is apparently essential for controlling Wnt signalling
activation [12,13].
As a single transmembrane protein, the amyloid precursor protein
(APP) is implicated in the pathogenesis of Alzheimer's disease (AD)
[14,15]. APP releases the soluble βAPP and a membrane-linked
C-terminal fragment (βCTFs)when cleaved by β-secretase. βCTFs is fur-
ther cleaved by γ-secretase in the membrane to release the β-amyloid
protein (Aβ) and the APP intracellular domain (AICD). A second protein,), L.zhang@lumc.nl (L. Zhang).
12 Published by Elsevier B.V. All rigα-secretase, cleaves within the Aβ region, creating soluble αAPP and a
membrane-linked C-terminal fragment (αCTFs), which is then further
processed by γ-secretase into the P3 peptide and the AICD [16]. Several
reports have shown that the AICD interacts with different proteins,
such as Fe65, X11, Shc, JIP1 (JNK Interacting Protein 1), and performs
various physiological and pathological functions [17–24]. The AICD was
also shown to associate with the tumour suppressor gene p53 and trig-
ger apoptosis through p53-dependentmechanisms [25–28]. Direct bind-
ing of endogenous AICD to the EGFR promoter indicates the important
role it plays in gene transcription and EGFR-mediated biological func-
tions [29].
In this study, a negative correlation between c-Myc gene expres-
sion and the AICD was found in N2a stable cells expressing various
APP constructs. The AICD was shown to inhibit c-Myc gene expres-
sion by suppressing Wnt/β-catenin signalling in a GSK3β kinase-
dependent manner. Restoration of AICD expression in Nicastrin-
deﬁcient MEF cells reduced β-catenin-induced transcription, indicating
that endogenous AICD is a negative regulator of canonical Wnt signal-
ling. We further demonstrated that the AICD associates with GSK3β
and promotes Axin–GSK3β complex formation, leading to enhanced
β-catenin poly-ubiquitination. We also showed that, as a Wnt suppres-
sor, the AICD inhibits cell proliferation and facilitates NGF in neuronal
cell differentiation, suggesting that the inhibition of Wnt signalling by
the AICD is involved in the development and maintenance of neuronal
cells.hts reserved.
Fig. 1. The AICD reduces Wnt-induced c-Myc expression. (a–c) Comparable c-Myc ex-
pression was analysed by semi-quantitative RT-PCR in cell lines as indicated. Actin
served as an internal control. (d) Endogenous c-Myc protein was immunoblotted in
controls and AICD expressing N2a cells. c-Myc-His-AICD was immunoblotted with an
anti-Myc antibody following Nickel beads pull down (Ni NTA PPT). Actin served as an
internal control. (e) The c-Myc promoter was coexpressed with AICD. 36 h later, cells
were harvested for luciferase analysis. 10 μM Aβ was added for 8 h before the cells
were harvested. (f) The c-Myc promoter was co-expressed with AICD, Wnt1, and
β-catenin as indicated. 36 h later, cells were harvested for luciferase analysis.
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2.1. Constructs and reagents
The pcDNA3.1/Myc-His AICD (C57, the last 57 AA of APP695 iso-
form) was previously described [30]. The pLV-bc-IRES-GFP-AICD
plasmid was constructed by insert AICD fragment into pLV-bc-IRES-
GFP vector. Inserted sequence was conﬁrmed by sequencing align-
ments. LEF-Luci, β-catenin▲N (45 amino acid deletion at N terminal),
β-catenin WT and SA (S29A, S33A, S37A, T41A and S45A), Dvl, LEF-
Luci, TopFlash-Luci, FopFlash-luci, GSK3β, HA-Axin and p21/p15 pro-
moter constructs were also previously described [31–37]. Monoclonal
antibody GSK3β (27C10), Phospho-GSK3β (Ser9), p15 and p16 anti-
bodies were provided by cell signalling technology, Inc (USA). Flag
(M2) antibody and Flag (M2) beads were from Sigma (USA). The
APP C-terminal speciﬁc 369 antibody was previously described
[38,39]. Antibodies for p21 and c-Myc were purchased from the
Beyotime Institute of Biotechonolgy (China), and SB216763 was
obtained from Tocris Bioscience (Missouri, USA).
2.2. Cell lines and cell culturing
HEK293T, MEF and Nct+/+ and Nct−/− ﬁbroblast cells were cul-
tured in Dulbecco's modiﬁed Eagle's medium (DMEM, GIBCO) sup-
plemented with 10% foetal bovine serum (Hyclone). PC12 cells
obtained from the Peking Union of Medical College (China) were cul-
tured in RPMI1640 medium (GIBCO) supplemented with 5% foetal
bovine serum and 10% foetal horse serum (Hyclone). N2a cells were
cultured in 50% Dulbecco's modiﬁed Eagle's medium and 50% OPTI-
MEM (GIBCO) supplemented with 5% foetal bovine serum and
200 μg/ml G418 (GIBCO) for stable cell lines. All cells were cultured
in a 5% CO2-containing atmosphere at 37 °C.
2.3. Transfection, immunoprecipitation, and immunoblotting
HEK293T cells were transiently transfected using either the calci-
um phosphate method or Lipofectamine (Invitrogen, USA). PC12, N2a,
MEF and Nct+/+ or Nct−/− cells were transiently transfected using
Lipofectamine 2000 (Invitrogen, USA). Immunoprecipitation and im-
munoblotting were performed as previously described [31,36,40].
2.4. Luciferase reporter assays
As previously described [30,40]; HEK293T, MEF and N2a cells were
transfected with various plasmids (as indicated in the relevant ﬁg-
ures). 36 h after transfection, the cells were harvested and luciferase
activities were measured using a luminometer (Berthold Technolo-
gies, Germany). Reporter activity was normalised to the control
Renilla. All experiments were repeated in triplicate.
2.5. Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNAwas isolated using Trizol (Roche, Switzerland), and geno-
mic DNA was removed by DNase (Takara, Japan). A total of 2 μg RNA
was reverse-transcribed at 42 °C for 45 min, in a 20 ml reactionmixture
using the Reverse Transcription System (Promega, USA). Expression
levels of c-Myc, and α-actin were detected by semi-quantitative PCR
using the following primer pairs: 5′-ACCAACAGGAACTATGACCTC-3′
(c-Myc forward), and 5′-GCCGCTCCACATACAGTCCT-3′(c-Myc reverse),
plus 5′-GGGTATGGAATCCTGTGGC-3′ (α-actin forward), and 5′-
AGTCCGCCTAGAAGCACTTG-3′ (α-actin reverse).
2.6. Ubiquitination detection
As previously described [36], cells were washed with PBS and
lysed in 2× volumes of pellet buffer (20 mM sodium phosphatepH7.4, 150 mM NaCl, 1% Triton, 0.5% Sodium-deoxycholate, and 1%
SDS) supplemented with protease inhibitors and 10 mM N-
Ethylmaleimide (NEM). Lysates were sonicated, boiled at 95 °C for
5 min, diluted into a RIPA buffer containing 0.1% SDS, and ﬁnally cen-
trifuged at 4 °C (16×103g for 15 min). The supernatant was then in-
cubated with a Flag antibody and protein A-Sepharose for 3 h at 4 °C.
After extensive washing, bound proteins were eluted into a 2× SDS
sample buffer and separated on SDS-PAGE, followed by western
blotting.
2.7. Measurement of neurite outgrowth in PC12 and N2a cells
As previously described [35], the effects of variables on neurite
outgrowth were analysed based on the length of the neurite out-
growth. Cells greater than one cell in diameter, bearing one or more
neurites, were deﬁned as differentiated cells. Data are reported as
the mean +/− standard error of the mean (SEM).
2.8. Primary neuron cultures and lentivirus infection
Primary neurons were obtained from embryonic days 16–18 ICR
mice. Brieﬂy, brains from the embryonic mice were removed and
the cortices were isolated in HBSS at 4 °C. The culture dish (35 mm)
was pretreated with poly-L-lysine (Sigma) for 24 h (100 μg/ml). The
cortical tissues were digested in 0.25% trypsin for 20 min at 37 °C,
and 50,000 cells were plated in each dish in DMEM containing 5% foe-
tal bovine serum and 5% foetal horse serum (Hyclone). On the next
day, the medium was replaced by Neuralbasal medium containing
B27 and Glutamax (Invitrogen). To investigate the effect of AICD on
1235F. Zhou et al. / Biochimica et Biophysica Acta 1823 (2012) 1233–1241development of neurites of primary neurons, 1:1 solution of lentivirus
supernatant and Neuralbasal medium was added to neurons on day 3
after plating. After 24 h, the medium was replaced with fresh
Neuralbasal medium. Infected neurons were ﬁxed in and immuno-
stained after 96 h.Fig. 3. Loss of the AICD in Nicastrin−/− MEF cells leads to higher responsiveness to
Wnt.Nicastrin+/+ MEF cells and Nicastrin−/− MEF cells were transiently transfected
with LEF-Luciferase reporter, Renilla, AICD and β-catenin as indicated. At 36 h post-2.9. Morphological analysis of infected neurons
The primary antibody used was MAP-2 (Rabbit, 1:500; Millipore).
The second antibody was Tritic (goat anti-rabbit, 1:100; Sigma). The
neurites were traced with NIH ImageJ. The neurite number and total
length of each GFP expressed neuron were analysed. Student's t test
was used to assess the signiﬁcance of three independent experiments.
In each experiment, ten to ﬁfteen cells were analysed. Data are
reported as +/− standard error of the mean (SEM). Pb0.05 was
used as the criterion of statistical signiﬁcance.transfection, cells were harvested for luciferase analysis. (n=3; asterisks, Pb0.05).
Centre panel: Western blotting with a 369 antibody following 369 immunoprecipitation
in Nicastrin+/+ and Nicastrin−/−MEF cells revealed different AICD and APP CTFs levels.2.10. Statistical analysis
Statistical analyses were performed with a two-tailed unpaired
t-test. Pb0.05 was considered statistically signiﬁcant.Fig. 2. The AICD inhibits canonical Wnt-responsive reporter activity. (a) The AICD was
co-expressed with Wnt (Wnt1 or Wnt3a) in HEK293T, N2a or MEF cells as indicated.
36 h post-transfection, cells were harvested for LEF-Luc luciferase analysis. (n=3; as-
terisks, Pb0.05; n=3, two asterisks, Pb0.01). (b) The AICD was co-expressed with
Wnt essential components LRP6 or Dishevelled (Dvl1/2/3) in N2a as indicated. 36 h
post-transfection, cells were harvested for TopFlash-Luc luciferase analysis. (n=3; as-
terisks, Pb0.05; n=3, two asterisks, Pb0.01). (c) The AICD was co-expressed with
wild-type (wt) or constitutively active β-catenin (β-catenin SA or β-catenin▲N
N-terminal deleted mutant) in HEK293T cells as indicated. 36 h post-transfection,
cells were harvested for TopFlash-Luc luciferase analysis. (n=3; asterisks, Pb0.05;
ns, non-speciﬁc).3. Results
3.1. AICD reduces Wnt induced c-Myc expression and inhibits canonical
Wnt responsive reporter activity
We determined that c-Myc gene expression was lower in N2a cells
that stably express APP (Fig. 1a). Similarly, c-Myc expression is lower
in N2a APPswe/PS1 deltaE9 cells than in N2a APPswe/PS1 cells [41]
(Fig. 1b). We also observed lower c-Myc protein level in those
comparisons (data not shown), indicating that presenilin 1 (PS1)Fig. 4. The AICD inhibits canonical Wnt signalling in a GSK3β kinase activity-dependent
manner. (a) PC12, HCT116 and SW480 cells were transiently transfected with LEF-Luc
reporter, Renilla and AICD as indicated. At 36 h post-transfection, cells were harvested
for luciferase analysis. (b) HEK293 cells were transiently transfected with TopFlash-Luc
or control FopFlash-Luc reporter, Renilla, AICD, GSK3β, and β-catenin as indicated. Six-
teen hours after transfection, SB216763 was added to inhibit GSK3β kinase activity. At
36 h post-transfection, cells were harvested for luciferase analysis. (n=3; asterisks,
Pb0.05).
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down-regulation. γ-secretase produces Aβ and AICD and we ob-
served lower c-Myc gene and protein expression in N2a cells express-
ing the AICD (Fig. 1c and d). Reporter assay analysis showed
consistently that the c-Myc promoter was suppressed by the AICD
but not by Aβ (Fig. 1e). Furthermore, Q-PCR analysis showed that
cyclin D1 expression was also lower in AICD-expressing N2a cells
(data not shown). The fact that c-Myc and cyclin D1 are direct target
genes of canonical Wnt signalling prompted us to evaluate whether
the AICD also counteracts Wnt/β-catenin mediated transcription.
Results in Fig. 1f conﬁrm that this is indeed the case. By using theFig. 5. The AICD associates with GSK3β and enhances its kinase activity. (a) Endogenous p
munoblotting. The endogenous AICD expression level was revealed by immunoblotting wit
βCTF, αCTF and AICD were indicated on both sides. Tubulin served as a loading control (l
HEK293T cells were transiently transfected with increasing amounts of Myc-His-AICD
phosphorylated (Ser9) GSK3β antibody (upper panels). Expression of the AICD was immun
shown as indicated. Tubulin served as a loading control (lower panels). Statistical analysis of tota
between GSK3β and the AICD. HEK293T cells were transiently transfected withMyc-AICD or co
precipitationwith anti-Myc antibodies. AICD-associatedGSK3βwas immunoblotted by anti-GSK
the total cell lysates (lower panels, 3% input). (d) Interactions between GSK3β and the AICD. HEK
At 36 h post-transfection, cells were harvested for immunoprecipitation with control IgG or an
The protein expression was conﬁrmed by anti-GSK3β or anti-Myc with total cell lysates (low
Axin, HA-GSK3β and Myc-AICD were co-expressed in HEK293T cells. Cells were harvested fo
antibodywas performed and immunoblottedwith anti-Flag, anti-HA and anti-Myc respectively
siently transfected withMyc-AICD and HA-Axin as indicated. At 36 h post-transfection, cells w
enous GSK3βwas revealed by anti-GSK3β immunoblotting (upper panel). The input protein exp
lysates (middle panels). Tubulin served as a loading control (lower panels). Statistical analysis
promotes β-catenin ubiquitination. HEK293T cells were transfected as indicated. 36 h late
immunoblotting.Wnt-transcriptional reporter constructs TopFlash–luciferase [42]
and LEF–luciferase [43], we directly tested the role of the AICD in ca-
nonical Wnt signalling. Wnt1- and Wnt3a-induced LEF-Luc reporter
activity was shown to be inhibited by the AICD in various cell types
(Fig. 2a). Similar results were observed using the TopFlash reporter
(data not shown). We then sought to understand how the AICD
plays a role in Wnt signalling, so we stimulated Wnt reporters with
several other downstream Wnt pathway components. As shown in
Fig. 2b and c, the AICD can inhibit Wnt signalling induced by LRP6, Di-
shevelled1/2/3 and β-catenin wild-type (wt), but has less of a role in
blocking signalling that strongly derives from constitutively activehosphorylated (Ser9) GSK3β protein levels in different cell lines were analysed by im-
h a 369 antibody, following immunoprecipitation with 369 antibodies (middle panels).
ower panels). (b) The AICD decreases the phosphorylated (Ser9) GSK3β protein level.
. The phosphorylated (Ser9) GSK3β protein level was immunoblotted with anti-
oblotted with anti-Myc antibody following Nickel beads pull down. Total GSK3β was
l andphosphorylated (Ser9)GSK3βwas shownon the right panels (n=3). (c) Interactions
ntrol pcDNA vector plasmids. At 36 h post-transfection, cells were harvested for immuno-
3β antibody. The input protein expressionwas conﬁrmed by anti-GSK3β or anti-Mycwith
293T cells were transiently transfectedwithMyc-AICD or control pcDNA vector plasmids.
ti-GSK3β antibodies. GSK3β-associated AICD was revealed by anti-Myc immunoblotting.
er panels, 3% input). (e) The AICD forms a trimeric complex with Axin and GSK3β. Flag-
r Flag beads immunoprecipitation and Flag-peptide elution. The second IP with anti-HA
. (f) The AICD enhances the interaction betweenGSK3β and Axin. HEK293T cellswere tran-
ere harvested for immunoprecipitation with an anti-HA antibody. Axin-associated endog-
ressionwas conﬁrmed by anti-Myc, anti-HA and anti-GSK3β antibodies with the total cell
of total and Axin associated GSK3β was shown on the right panels (n=3). (g) The AICD
r, cells were harvested, denatured and diluted for Flag immunoprecipitation and HA
1237F. Zhou et al. / Biochimica et Biophysica Acta 1823 (2012) 1233–1241β-catenin (SA mutant or ▲N-terminal mutant). These results suggest
that the AICD may antagonise Wnt signalling in a β-catenin destruc-
tion complex-dependent manner.3.2. The loss of AICD in Nicastrin knock-out MEF cells leads to higher
responsiveness to Wnt
We next tested whether endogenous AICD plays a negative role in
the Wnt pathway. As a product of APP cleavage, speciﬁc silencing of
AICD expression could not be obtained through RNA interference.
Therefore, we performed Wnt reporter assays in Nct−/− MEF cells
where both the γ-secretase cleavage and AICD production were
blocked due to defective γ-secretase complexes [44] (Fig. 3). As
shown in Fig. 3, Wnt signalling was initiated at a much lower rate
by β-catenin in Nct+/+ cells than in Nct−/− cells. The β-catenin po-
tentiated transcriptional activity is severely down-regulated upon
restoration of the AICD by transfection. This result suggests thatFig. 6. The AICD cooperates with NGF to suppress neuronal cell proliferation in N2a and PC12
and facilitates NGF to enhance the promoter activity of p21 in PC12 cells (c). N2a or PC12 cel
At 16 h post-transfection, NGF was added as indicated. Thirty-six hours after transfection, t
protein expression of p15, p16 and p21 in PC12 cells. PC12 cells were transiently transfected
cells were treated with three doses of NGF (50 ng/ml, 100 ng/ml, 150 ng/ml) for 54 h. Endog
proliferation of N2a (E) and PC12 (F) cells. The cell proliferation was analysed using the Ceendogenous AICD may play a similar role in order to suppress Wnt
signalling.
3.3. The AICD inhibits canonical Wnt signalling in a GSK3β kinase
activity dependent manner
The AICD lost its capability to suppress Wnt reporter activity acti-
vated by truncated β-catenin▲N or β-catenin SA, which are the mu-
tants that resistant to phosphorylation by GSK3β. Therefore, the
AICD may counteract Wnt signalling in a GSK3β kinase activity-
dependent manner. To prove this, we performed reporter assays in
colon cancer cell lines. SW480 and HCT116 cell lines with mutations
in the APC and β-catenin genes respectively would be expected to
lead to abnormal localisation and continuous activation of β-catenin
[45]. As shown in Fig. 4a, the AICD showed a strong inhibitory effect
in PC12 cells (where APC and β-catenin were normal) than in
HCT116 cells (β-catenin mutant) or in SW480 cells (APC mutant).
In addition, the AICD cooperated with GSK3β in antagonising Wntcells. (a–c) The AICD promotes the promoter activity of p15 (a) and p21 (b) in N2a cells
ls were transiently transfected with a p15 promoter or p21 promoter, Renilla and AICD.
he cells were harvested for luciferase analysis. (d) AICD facilitates NGF to promote the
withMyc-His-AICD or control pcDNA vector plasmid. Sixteen hours after transfection,
enous protein levels were analysed by immunoblotting. (e–f) The AICD inhibits the cell
ll Counting Kit-8 (CCK-8).
Fig. 7. The AICD promotes NGF-induced neurite outgrowth in N2a and PC12 cells. (a) The
AICDpromotesNGF to induceneurite outgrowth in PC12 cells. PC12 cellswere transfected
with AICD and stimulated with NGF as indicated. At 48 h post-transfection, cells were ob-
served inmicroscopy and numbered. Datawere reported as themean+/− standard error
of themean (SEM).n=3. Pb0.05.Upper panels: images of neurite outgrowth in PC12 cells.
Middle panels: Expression of Myc-His-AICD was revealed by Nickel beads pull down and
anti-Myc immunoblottings. (b) The AICD antagonises Wnt3a-suppressed neurite out-
growth in N2a cells. N2a wt and N2a–AICD stably expressing cell lines were seeded in
35-mm dishes and treated with NGF or NGF+Wnt3a as indicated. 48 h later, cells were
observed in microscopy and numbered. Data were reported as the mean +/− standard
error of the mean (SEM). Middle panels: Expression of Myc-His-AICD was revealed by
Nickel beads pull down and anti-Myc immunoblottings. n=3. Pb0.05.
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SB216763, the GSK3β kinase inhibitor (Fig. 4b). Taken together, these
results suggest that the AICD inhibits Wnt in GSK3β kinase-dependent
manner.
3.4. The AICD associates with GSK3β and enhances its kinase activity
We next investigated the underlying mechanism. Comparison of
N2a APPswe/PS1, N2a APPswe/PS1 385, and N2a APPswe/PS1deltaE9
stable cells showed a negative correlation between endogenous
AICD and GSK3β phosphorylation at the serine residue at position 9
of the protein (Ser 9) (Fig. 5a). Consistently, increasing the amount
of exogenous AICD resulted in activation of the endogenous GSK3β
kinase as indicated by decreased Ser 9 phosphorylation (Fig. 5b).
These data showed that the AICD activates GSK3β. To test whether
the AICD could bind to GSK3β, we performed immunoprecipitation
assays. Endogenous GSK3β was found in anti-Myc immunoprecipita-
tions of HEK293T cells transfected with Myc-tagged AICD, but not in
the cells transfected with an empty vector (Fig. 5c). Conversely, the
AICD was found in immunoprecipitation with a GSK3β antibody
(Fig. 5d), suggesting that the AICD can interact with GSK3β. In Wnt
signalling, GSK3β is recruited to a multi-protein complex by interac-
tions with Axin and APC, which protects the kinase activity. β-catenin
is then hyper-phosphorylated, ubiquitinated and degraded [46]. Ectop-
ically expressed AICD was found in a trimeric complex with Axin and
GSK3β (Fig. 5e). Additionally, we found that the association between
Axin and endogenous GSK3β was elevated by the AICD (Fig. 5f). AICD
induced the poly-ubiquitination of β-catenin and accelerated its degra-
dation (Fig. 5e and data not shown). Taken together, these data indicate
that the AICD binds and activates GSK3β, thereby inhibiting Wnt
signalling.
3.5. The AICD cooperates with NGF to suppress neuronal cell proliferation
The Wnt pathway is essential for cell proliferation. The above data
unravelled an interplay between Wnt signalling and the AICD. We
then explored the effect of AICD on cell proliferation. Consistent
with its role as a negative regulatory factor in Wnt signalling, the
AICD activated the expression of CDK inhibitors, such as p15, p16
and p21, which were detected either by the promoter activity or the
endogenous protein expression (Fig. 6a–d). Interestingly, the AICD
was shown to facilitate the induction of CDK inhibitors induced by
nerve growth factor (NGF) (Fig. 6c and d). Analysis of cell prolifera-
tion assays further conﬁrmed that the AICD could also cooperate
with GSK3β and NGF in blocking neuronal cell proliferation (Fig. 6e
and f). These results suggest that the AICD inhibits cell proliferation
by inducing cell cycle CDK inhibitors.
3.6. AICD promotes NGF-induced neurite outgrowth by antagonising
Wnt signalling
Downregulation of Wnt signalling is required for cell differentia-
tion [47,48]. It is well established that NGF can induce neurite out-
growth in rat pheochromocytoma PC12 cells as an indicator of
neural differentiation. Based on the results above, we hypothesised
that the AICD may play a role in neuronal cell differentiation. As
shown in neuronal differentiation assays, the AICD could promote
and greatly enhance the ability of NGF in the induction of neurite out-
growth (Fig. 7a). To determine whether this effect is due to antago-
nism of canonical Wnt by the AICD, we treated control and AICD
ectopic expressed N2a cells with NGF and Wnt3a. As shown in
Fig. 7b, Wnt3a blocked NGF from inducing neurite outgrowth in con-
trol cells, but not in AICD-expressing cells. Therefore, these data un-
cover the role of the AICD in promoting NGF-induced neuronal cell
differentiation as a Wnt repressor.We also explored the effect of AICD on neurite extension in prima-
ry neurons. Lentivirus introduced AICD (IRES GFP) expression in
mouse primary neuron signiﬁcantly increases total neurite length
without altering neurite numbers (Fig. 8a and b and data not shown).4. Discussion
As a by-product of APP that has been cleaved by γ-secretase, the
AICD increases along with Aβ in AD patients. Aβ attracts most of the
research interest, while AICD has only begun to be studied in the lat-
est decade. As a very unstable small protein, the existence of the AICD
has been disputed since the day it was discovered, primarily due to
technical difﬁculties in detecting its existence. Although the function
of AICD in the regulation of gene expression has been reported
[49,50], some groups still doubt the usefulness of the AICD [51].
The ﬁndings presented here reveal the critical role of the AICD in
the regulation of canonical Wnt signalling. Our studies identiﬁed the
AICD as a suppressor of endogenous c-Myc expression. Subsequent
investigations have linked this observation to the role of the AICD in
antagonising Wnt/β-catenin signalling, which were analysed in detail
using a well establishedWnt-cascade detecting method. At a molecu-
lar level, the AICD was shown to associate with and activate GSK3β,
thereby promoting the ubiquitination of β-catenin. These results are
consistent with a previous study, which showed that GSK3β is acti-
vated in AICD transgenic mice [52], although the exact mechanism
by which the AICD activates GSK3β needs to be further determined.
Although some groups have shown that stimulation of GSK3β results
in neurite retractions [53], we found that activation of GSK3β by the
AICD actually enhances neurite outgrowth in PC12, N2a cells and pri-
mary neurons.
Fig. 8. AICD promotes neurite length in primary neuron. (a) Representative image (#1 and #2) of primary neuron introduced through lentivirus infection with control plv IRES GFP
vector (Co.vector) or AICD IRES GFP overexpression. MAP2 (red signal) shows as a neuronal marker. (b) Statistically analysis of total neurite length of control (Co.vec) and AICD-
overexpressed primary neurons. Experiments were repeated three times and 10–15 primary neurons were calculated every time. Pb0.05.
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ling also contributes to suppressing NGF-induced neurite differentia-
tion [54]. At a cellular level, AICD-mediated suppression of Wnt
signalling was shown to inhibit neural cell proliferation and promote
neural cell differentiation. A recent study using microarrays in neuro-
blastoma cells discovered that the AICD upregulates genes such as
IGFBP3 and TAGLN, which are related to cytoskeletal dynamics and
are critical to cell differentiation. This ﬁnding also suggests an effect
of the AICD on neural cell differentiation [55]. Importantly, it has
been reported that APP is involved in cell adhesion, cell growth, neu-
rite outgrowth, and neuron protection. Hippocampal neurons from
APP-deﬁcient mice had diminished viability and retarded neurite de-
velopment [56]. In addition, neurological evaluations showed that
APP-deﬁcient mice exhibited a decreased locomotor activity and fore-
limb grip strength in the presence of an APP null mutation. This indi-
cates an impaired neuronal and muscular function [57]. Since the
AICD is a cleavage product of APP, and this study showed its potential
neural-protective role, whether the impaired neurite development in
APP-deﬁcient mice is due to loss of AICD needs to be further
investigated.
APP shares similar proteolysis with Notch, a key protein in the
Notch signal transduction pathway that controls cell fate in meta-
zoans. This raises the intriguing possibility that APP is a cell surface
receptor that also transduces signals by releasing and transporting
the AICD into the nucleus. Several studies have demonstrated that
the AICD can relocate from the cytoplasm into the nucleus, thus pro-
moting gene transcription and inducing apoptosis [50,58,59]. In this
study, we linked the AICD to the regulation of canonical Wnt signal-
ling. Therefore, a potential area of future research could involve ex-
amining whether the previously identiﬁed multifunctional AICD
effects are mediated by its ability to function as a regulator of Wntsignalling. Interestingly, we have previously shown that canonical
Wnt/β-catenin signalling stabilises the AICD [30]. Here we provide
evidence that a higher level of AICD activates GSK3β and down regu-
lates β-catenin-mediated transcription. Therefore, the AICD may
serve as a negative feedback regulator of Wnt activation. If this is
the case, a Wnt-initiated, APP-mediated negative feedback loop exists
in neuronal cells. These results also indicate that the existence of a
well-balanced AICD is important in vivo.
Crosstalk between AD and Wnt-related tumourigenesis has also
been studied in recent years. PS1, the active core of the γ-secretase
complex, has been reported to interact with β-catenin through E-
cadherin and the negatively-regulated Wnt/β-catenin pathway [60].
PS1 knockout mice that are rescued through neuronal expression of
a human PS1 transgene are known to develop spontaneous skin can-
cers as a result of the upregulated β-catenin/LEF signalling and con-
current activation of cyclin D1 [61]. Here we offer a new clue that
the AICD is also involved in the tumourigenesis-related Wnt signal-
ling pathway. Since PS1 knockout greatly impairs the γ-secretase ac-
tivity, thereby leading to reduced AICD production, loss of the AICD
may also contribute to the development of spontaneous skin cancers,
but this hypothesis is still awaiting conﬁrmation.
Although much more work is needed to elucidate the exact role of
the AICD in neuronal cell development and AD, the present study
showed that the AICD modulates neural cell proliferation and differ-
entiation as a negative regulator of the canonical Wnt signalling
pathway.
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